Loading clinical trials...
Loading clinical trials...
A Phase 3, Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 11 to 55 Years of Age in Korea
Conditions
Interventions
Novartis MenACWY-CRM
Saline Placebo
Locations
8
South Korea
Department of Pediatrics, Kosin University Gospel Hospital
Busan, South Korea
Department of Pediatrics, Seoul National University Bundang Hospital
Gyeonggi-do, South Korea
Deaprtment of Pediatrics, Inha University Hospital
Incheon, South Korea
Division of Infectious Diseases, Inha University Hospital
Incheon, South Korea
Pediatrics and Adolescent medicine, Myongji Hospital Kwandong University
Kyunggi, South Korea
Department of Pediatrics, Ewha Womans University Mokdong Hospital
Seoul, South Korea
Start Date
December 1, 2010
Primary Completion Date
March 1, 2011
Completion Date
March 1, 2011
Last Updated
October 16, 2012
NCT06131554
NCT01725217
NCT02842866
NCT03205358
NCT03694405
NCT04358731
Lead Sponsor
Novartis Vaccines
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions